📰 Roche Diagnostics News
Page 39 - Roche Diagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Roche Diagnostics. Real-time updates on events, politics, business and more.
December 1, 2022
BOSTON, MA - Quarterra Multifamily, a subsidiary of Lennar Corporation and a vertically integrated multifamily apartment builder, developer, and asset manager, announced the start of construction at Harper, a mid-rise community in the Boston neighborhood of Allston, known as the citys hub for public art and music. Harper brings 265 apartment homes to Allston, which is named after American painter and poet Washington Allston. Fittingly, Allston is renowned for its collection of murals and...
December 1, 2022
/PRNewswire/ -- The "Europe Biopsy Devices Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis"...
November 30, 2022
/PRNewswire/ -- The "United States Molecular Diagnostics Market, Size, Share, Forecast 2022-2027, Industry Trends, Growth, Insights, Impact of COVID-19,...
November 30, 2022
/PRNewswire/ -- The "United States Liquid Biopsy Market, Size, Global Forecast 2022-2027, Industry Trends, Growth, Outlook, Impact of COVID-19, Company...
November 30, 2022
/PRNewswire/ -- The "United States Liquid Biopsy Market, Size, Global Forecast 2022-2027, Industry Trends, Growth, Outlook, Impact of COVID-19, Company...
November 30, 2022
/PRNewswire/ -- The "United States Molecular Diagnostics Market, Size, Share, Forecast 2022-2027, Industry Trends, Growth, Insights, Impact of COVID-19,...
November 25, 2022
CHICAGO, Nov. 25, 2022 /PRNewswire/ -- HPV Testing and Pap Test Market is projected to reach USD 9.2 billion by 2027 from USD 4.9 billion in 2022, at a CAGR of 13.2% according to a new report
November 25, 2022
/PRNewswire/ -- HPV Testing and Pap Test Market is projected to reach USD 9.2 billion by 2027 from USD 4.9 billion in 2022, at a CAGR of 13.2% according to a...
November 23, 2022
SAE Media Group reports: Network with the pharma and biotech global experts from UK and Europe at the RNA Therapeutics conference in London.
November 23, 2022
Accurate identification of mosquito species is essential for the development and optimization of strategies to control mosquitoes and mosquito-borne diseases. Problems with the morphological identification of mosquito species have led to the use of molecular identification techniques, in particular the Folmer cytochrome c oxidase subunit I (COI) PCR system (FCOS), originally designed to identify a range of other invertebrates. As there can be difficulties identifying mosquitoes using FCOS, we re...